Szerző: " Zielinski Christoph"

Pascual Javier; Gil-Gil Miguel; Proszek Paula; Zielinski Christoph; Reay Alistair; Ruiz-Borrego Manuel; Cutts Rosalind; Ciruelos Gil Eva M; Feber Andrew; Muñoz-Mateu Montserrat; Swift Claire; Bermejo Begoña; Herranz Jesus; Kahán Zsuzsanna; Csöszi Tibor: Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.
CLINICAL CANCER RESEARCH, 29 (20). pp. 4166-4177. ISSN 1078-0432 (2023)

Thallinger Christiane; Berzinec Peter; Bicakcic Emina; Dan Adelina; Fábián Gabriella; Gales Laurentia Nicoletta; Kuhar Cvetka Grasic; Janzic Urska; Kahán Zsuzsanna; Mencinger Marina; Penthedourakis George; Sgouros Joseph; Simetic Luka; Sirbu Daniela; Vosmik Milan; Wrona Anna; Zielinski Christoph: Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe An initiative of the Central European Cooperative Oncology Group (CECOG).
WIENER KLINISCHE WOCHENSCHRIFT: MIDDLE EUROPEAN JOURNAL OF MEDICINE, 134 (19-20). pp. 697-704. ISSN 0043-5325 (2022)

Zielinski Christoph; Láng István; Beslija Semir; Kahán Zsuzsanna; Inbar Moshe J.; Stemmer Salomon M.; Anghel Rodica; Vrbanec Damir; Messinger Diethelm; Brodowicz Thomas: Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.
BRITISH JOURNAL OF CANCER, 114. pp. 163-170. ISSN 0007-0920 (2016)

Brodowicz Thomas; Láng István; Kahán Zsuzsanna; Greil R.; Beslija Semir; Stemmer Salomon M.; Kaufman B.; Petruzelka L.; Eniu A.; Anghel Rodica; Koynov K.; Vrbanec Damir; Pieńkowski Tadeusz; Melichar B.; Spanik S.; Ahlers S.; Messinger Diethelm; Inbar Moshe J.; Zielinski Christoph: Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
BRITISH JOURNAL OF CANCER, 111 (11). pp. 2051-2057. ISSN 0007-0920 (2014)